![](/img/cover-not-exists.png)
[American Thoracic Society American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California - ()] B41. COPD: PHARMACOLOGICAL TREATMENT - Pearl Therapeutics' Formoterol Fumarate MDI (FF-MDI, PT005) Demonstrates Pharmacokinetic Bioequivalence To Foradil® Aerolizer® In A Randomized, Double-Blind, Single Dose, Six-Treatment, Placebo-Controlled, Crossover Phase 2b Study In Patients With Moderate To Severe Chronic Obstructive Pulmonary Disease
Orevillo, Chadwick J., Fogarty, Charles, Dunn, Leonard, Parrino, Jack, St. Rose, Earl, Fernandez, Carlos, Covino, Joseph, Fischer, Tracy, Strom, Shannon, Vasilinin, Grygoriy, Marier, J F., Reisner, CoYear:
2012
Language:
english
DOI:
10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2929
File:
PDF, 19 KB
english, 2012